Afanat 40mg

About Afanat 40mg

Afanat 40mg is used for the treatment of non-small cell lung cancer (NSCLC), specifically targeting tumors with specific EGFR (epidermal growth factor receptor) mutations. This targeted therapy contains Afatinib Dimaleate, a kinase inhibitor that works by irreversibly blocking signaling pathways essential for cancer cell growth and survival. Manufactured by Natco Pharma Ltd., this medication represents an important advancement in precision oncology, offering hope to patients whose cancers harbor deletions in exon 19 or exon 21 (L858R) substitution mutations. For patients requiring dose adjustments based on tolerability, physicians may consider Afanat 30mg or Afanat 20mg as alternative strength options. Unlike broader chemotherapy agents such as Bosuvi 100mg (Bosutinib), which targets different cancer pathways, Afatinib specifically inhibits the HER family of receptors, making it particularly effective for EGFR-mutated lung cancers.

Dosage & Usage

To take Afanat 40mg correctly, swallow one tablet orally once daily on an empty stomach, at least one hour before or two hours after a meal. This timing is critical because food significantly reduces the absorption of Afatinib. Take the medication at the same time each day to maintain consistent blood levels. Do not crush, chew, or break the tablet. If you miss a dose and it is more than 12 hours until your next scheduled dose, take the missed dose immediately; otherwise, skip it and resume your regular schedule. Your oncologist may adjust your dosage to 30mg or 20mg based on your tolerance to side effects such as diarrhea, rash, or stomatitis. Common side effects include skin reactions and gastrointestinal disturbances, which should be managed promptly with your healthcare team to maintain treatment continuity.

Who Is It For?

Afanat 40mg is safe for adult patients diagnosed with metastatic non-small cell lung cancer whose tumors have been confirmed to have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations through validated testing. This medication is not appropriate for patients with severe liver impairment, those who are pregnant or breastfeeding, or individuals with certain heart conditions including symptomatic left ventricular dysfunction. Patients should undergo EGFR mutation testing before starting therapy, as the medication is ineffective against EGFR-negative tumors. Similar to how targeted therapies like Apnat 60mg (Apalutamide) require specific biomarker confirmation for prostate cancer, Afatinib demands precise genetic profiling. Your oncologist will evaluate your overall health status, kidney function, and current medications to determine if this treatment is appropriate for your specific situation.

Why Buy From SafeRxPills?

SafeRxPills is a fully licensed online pharmacy committed to providing genuine life-saving medications to patients in Australia, the United Kingdom, the United States, and Canada. We understand the urgency of cancer treatment and ensure discreet packaging with delivery typically completed within 7-14 business days. Every tablet of Afanat 40mg we dispense is sourced directly from Natco Pharma Ltd., guaranteeing authenticity and quality. Our dedicated pharmacist support team is available to answer questions about your medication, potential interactions, and proper storage. We maintain strict privacy standards and use secure payment processing to protect your sensitive health information. When facing a serious diagnosis, having reliable access to essential medications matters—SafeRxPills provides that assurance with professional service and compassionate care.